[go: up one dir, main page]

IL114128A0 - Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms - Google Patents

Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms

Info

Publication number
IL114128A0
IL114128A0 IL11412895A IL11412895A IL114128A0 IL 114128 A0 IL114128 A0 IL 114128A0 IL 11412895 A IL11412895 A IL 11412895A IL 11412895 A IL11412895 A IL 11412895A IL 114128 A0 IL114128 A0 IL 114128A0
Authority
IL
Israel
Prior art keywords
treatment
composition
withdrawal symptoms
nicotine craving
smoking withdrawal
Prior art date
Application number
IL11412895A
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL114128A0 publication Critical patent/IL114128A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL11412895A 1994-06-23 1995-06-13 Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms IL114128A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26455494A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
IL114128A0 true IL114128A0 (en) 1995-10-31

Family

ID=23006582

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11412895A IL114128A0 (en) 1994-06-23 1995-06-13 Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms

Country Status (6)

Country Link
AU (1) AU2770895A (en)
IL (1) IL114128A0 (en)
MA (1) MA23587A1 (en)
PE (1) PE41096A1 (en)
WO (1) WO1996000070A1 (en)
ZA (1) ZA955031B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0828489A4 (en) * 1996-03-13 2001-04-04 Univ Yale TREATMENTS FOR QUITTING SMOKING INVOLVING THE USE OF NALTREXONE AND RELATED COMPOUNDS
WO1997034605A1 (en) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
EP0906089B1 (en) * 1996-05-13 2003-08-27 Novartis Consumer Health S.A. Buccal delivery system
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6949264B1 (en) 1996-11-27 2005-09-27 Wm. Wrigley Jr. Company Nutraceuticals or nutritional supplements and method of making
US6165516A (en) * 1996-11-27 2000-12-26 Wm. Wrigley Jr. Company Method of controlling release of caffeine in chewing gum
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
AU784112B2 (en) 1999-04-06 2006-02-09 Wm. Wrigley Jr. Company Pharmaceutical chewing gum formulations
US7115288B2 (en) 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
DE20018196U1 (en) 2000-10-25 2001-01-11 Peter, Michael N., 22297 Hamburg Confectionery product for smoking cessation
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
JP2007516149A (en) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ， インコーポレイテッド Method for controlling uniformity of substrate temperature, built-in heating unit and chemical supply unit using the same
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
WO2005046363A2 (en) 2003-11-07 2005-05-26 U.S. Smokeless Tobacco Company Tobacco compositions
US8627828B2 (en) * 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2246086A3 (en) 2004-08-12 2012-11-21 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heating unit
ES2594867T3 (en) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
EP2654738B1 (en) * 2010-12-21 2018-04-18 Fertin Pharma A/S Chewing gum composition comprising cross-linked polyacrylic acid
KR102852740B1 (en) 2018-02-02 2025-08-29 알렉스자 파마스티칼즈, 인크. Electrical Condensation Aerosol Device
CA3173292A1 (en) * 2020-09-03 2022-03-10 Walid Abi Aoun Aerosol-generating material for oral caffeine delivery
CN115590855A (en) * 2022-10-26 2023-01-13 江南大学（Cn） A method for reducing nicotine content in nicotine products

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617418C3 (en) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Manufacture of solid drug forms with delayed release of active ingredients
DE1901277A1 (en) * 1969-01-10 1970-08-06 Partipharm Ag Chewing gum to com ensate for excessive - cigarette smoking
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (en) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg DEVICE FOR THE DEWNING OF EATING, DRINKING, SMOKING AND / OR ADDICTIVE Habits
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
DK365389D0 (en) * 1989-07-24 1989-07-24 Fertin Lab As ANTIFUNGAL CHEMICAL GUM PREPARATION
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency
FI913526L (en) * 1990-08-23 1992-02-24 Wrigley W M Jun Co CHEWING GUM WITH MOISTURE CONTAINER.

Also Published As

Publication number Publication date
MA23587A1 (en) 1995-12-31
PE41096A1 (en) 1996-10-08
ZA955031B (en) 1996-02-08
AU2770895A (en) 1996-01-19
WO1996000070A1 (en) 1996-01-04

Similar Documents

Publication Publication Date Title
IL114128A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
AU2703795A (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
IL114129A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
EP0713655A3 (en) Cigarette substitute article and method of making the same
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
PL318153A1 (en) Smoking article and cigarette of low co content
IL114130A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
EP0632969A3 (en) Filtertow and process for its manufacture as well as tobacco smoke filter and process for its manufacture.
EP0632968A3 (en) Filtertow and process for its manufacture and tobacco smoke filter and process for its manufacture.
EP0777473A4 (en) Compositions and methods for the control of smoking
IL126683A0 (en) Pharmaceutical composition and method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock
ZA938094B (en) Process for adjesting the moisture content of tobacco
AU3879789A (en) Use of benzo(g)quinolines in treatment of nicotine addiction
GB9404707D0 (en) Filter for smoking article and smoking article incorporating it
EP0496148A3 (en) Improvements in the treatment of ashes
AU8096094A (en) Use of nicotine substitutes for the treatment of nicotine withdrawal
GB2222066B (en) Method of increasing the hardness of cigarette filter elements
GB9410482D0 (en) Tobacco smokers' mouthpiece
GB8721504D0 (en) Nicotine level reduction in cigarettes
AU2446895A (en) Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers
GB9304027D0 (en) Packet for blocks of cigarettes and the like
ZA959717B (en) Tobacco rod and/or filter for smoking article
IL110749A0 (en) Smoker's device for reducing the consumption of cigarettes
EP0443749A3 (en) Cigarette or cigar
GB9325247D0 (en) Smokers'ashtray